142 related articles for article (PubMed ID: 35902716)
1. Impact of active surveillance for prostate cancer on the risk of depression and anxiety.
Sypre D; Pignot G; Touzani R; Marino P; Walz J; Rybikowski S; Maubon T; Branger N; Salem N; Mancini J; Gravis G; Bendiane MK; Bouhnik AD
Sci Rep; 2022 Jul; 12(1):12889. PubMed ID: 35902716
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
Punnen S; Cowan JE; Dunn LB; Shumay DM; Carroll PR; Cooperberg MR
BJU Int; 2013 Jul; 112(2):E67-75. PubMed ID: 23795800
[TBL] [Abstract][Full Text] [Related]
4. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract][Full Text] [Related]
6. Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
Kendel F; Helbig L; Neumann K; Herden J; Stephan C; Schrader M; Gaissmaier W
Int J Cancer; 2016 Aug; 139(4):749-53. PubMed ID: 27038059
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
8. Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Degeling K; Corcoran NM; Pereira-Salgado A; Hamid AA; Siva S; IJzerman MJ
Value Health; 2021 Dec; 24(12):1737-1745. PubMed ID: 34838271
[TBL] [Abstract][Full Text] [Related]
9. The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis.
Couper JW; Love AW; Dunai JV; Duchesne GM; Bloch S; Costello AJ; Kissane DW
Med J Aust; 2009 Apr; 190(S7):S86-9. PubMed ID: 19351300
[TBL] [Abstract][Full Text] [Related]
10. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
Thomsen FB; Røder MA; Jakobsen H; Langkilde NC; Borre M; Jakobsen EB; Frey A; Lund L; Lunden D; Dahl C; Brasso K
Clin Genitourin Cancer; 2019 Aug; 17(4):e814-e821. PubMed ID: 31196798
[TBL] [Abstract][Full Text] [Related]
11. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: A longitudinal study.
Meissner VH; Peter C; Ankerst DP; Schiele S; Gschwend JE; Herkommer K; Dinkel A
Cancer Med; 2023 Feb; 12(4):4842-4851. PubMed ID: 36254563
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
14. Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
van den Bergh R; Gandaglia G; Tilki D; Borgmann H; Ost P; Surcel C; Valerio M; Sooriakumaran P; Salomon L; Briganti A; Graefen M; van der Poel H; de la Taille A; Montorsi F; Ploussard G;
Eur Urol Focus; 2019 Mar; 5(2):171-178. PubMed ID: 28801241
[TBL] [Abstract][Full Text] [Related]
15. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study.
Plym A; Clements M; Voss M; Holmberg L; Stattin P; Lambe M
BMJ Open; 2020 Mar; 10(3):e032914. PubMed ID: 32156761
[TBL] [Abstract][Full Text] [Related]
16. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in men undergoing active surveillance for localized prostate cancer.
Bergman J; Litwin MS
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780
[TBL] [Abstract][Full Text] [Related]
19. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
20. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Bokhorst LP; Valdagni R; Rannikko A; Kakehi Y; Pickles T; Bangma CH; Roobol MJ;
Eur Urol; 2016 Dec; 70(6):954-960. PubMed ID: 27329565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
